Viewing Study NCT07264959

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:40 PM
Ignite Modification Date: 2026-02-03 @ 1:52 AM
Study NCT ID: NCT07264959
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-04
First Post: 2025-11-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
Sponsor: Blueprint Medicines Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Indolent Systemic Mastocytosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ISM View
None Avapritinib View
None BLU-285 View
None Selective KIT mutation-targeted tyrosine kinase inhibitor View
None Tyrosine kinase inhibitor View
None Mastocytosis View
None Neoplastic mast cells View